Treace Medical Concepts (TMCI) Profit After Tax (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Profit After Tax for 7 consecutive years, with -$15.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Profit After Tax rose 8.65% year-over-year to -$15.9 million; the trailing twelve-month figure through Jun 2026 stood at -$59.6 million (down 20.91% YoY), and the FY2025 full-year result was -$59.0 million, down 5.77% from the prior year.
• Profit After Tax rose to -$15.9 million in Q2 2026 per TMCI's latest filing, from -$18.0 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$567000.0 in Q4 2024 and bottomed at -$21.2 million in Q2 2024.
• Historically, Profit After Tax has averaged -$13.4 million across 5 years, with a median of -$15.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax soared 90.8% in 2024, then plunged 1558.73% in 2025.
• Over 5 years, Profit After Tax stood at -$4.4 million in 2022, then slumped by 38.77% to -$6.2 million in 2023, then jumped by 90.8% to -$567000.0 in 2024, then slumped by 1558.73% to -$9.4 million in 2025, then slumped by 69.05% to -$15.9 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$15.9 million, -$18.0 million, and -$9.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.